Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Fusion Pharmaceuticals Inc. (FUSN) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/09/2023 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 500,000 options to buy @ $3.75, valued at $1.9M
01/09/2023 4 Rawat Mohit (President and CBO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 300,000 options to buy @ $3.75, valued at $1.1M
01/09/2023 4 Leamon Christopher P (Chief Scientific Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 250,000 options to buy @ $3.75, valued at $937.5k
01/09/2023 4 Crowley John J (CFO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 250,000 options to buy @ $3.75, valued at $937.5k
01/09/2023 4 Burak Eric (Chief Technology Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 250,000 options to buy @ $3.75, valued at $937.5k
11/14/2022 4 Khuong Chau Quang (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 42,093 shares @ $2.38, valued at $100.2k
11/07/2022 4 Bobilev Dmitri (Chief Medical Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 550,000 options to buy @ $1.98, valued at $1.1M
08/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Lee Philina (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 17,000 options to buy @ $3.6, valued at $61.2k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 2,036 shares @ $6.03, valued at $12.3k
Sold 2,147 shares @ $6.07, valued at $13k
Sold 4,511 shares @ $6.03, valued at $27.2k
04/22/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 367 shares @ $6.02, valued at $2.2k
Sold 922 shares @ $6.01, valued at $5.5k
04/13/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 2,600 shares @ $7.37, valued at $19.2k
Sold 18,255 shares @ $7.1, valued at $129.6k
Sold 11,994 shares @ $6.41, valued at $76.9k
04/08/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 100 shares @ $7.58, valued at $758
Sold 1,255 shares @ $7.56, valued at $9.5k
Sold 826 shares @ $7.52, valued at $6.2k
04/05/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 1,000 shares @ $7.75, valued at $7.8k
Sold 700 shares @ $7.81, valued at $5.5k
Sold 2,100 shares @ $7.67, valued at $16.1k
04/01/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 300 shares @ $7.52, valued at $2.3k
03/29/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 500 shares @ $7.42, valued at $3.7k
Sold 9,600 shares @ $7.55, valued at $72.5k
Sold 200 shares @ $7.52, valued at $1.5k
03/24/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 4,000 shares @ $7.53, valued at $30.1k
Sold 100 shares @ $7.5, valued at $750
Sold 700 shares @ $7.46, valued at $5.2k
03/21/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 900 shares @ $7.51, valued at $6.8k
Sold 1,204 shares @ $7.61, valued at $9.2k
Sold 1,500 shares @ $7.47, valued at $11.2k
03/16/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 1,300 shares @ $6.96, valued at $9k
Sold 100 shares @ $7.12, valued at $712
Sold 100 shares @ $6.99, valued at $699
03/14/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 822 shares @ $6.94, valued at $5.7k
Sold 1,900 shares @ $7.06, valued at $13.4k
Sold 100 shares @ $7.13, valued at $713
03/08/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 8,400 shares @ $7.32, valued at $61.5k
Sold 3,100 shares @ $6.99, valued at $21.7k
Sold 3,004 shares @ $6.92, valued at $20.8k
03/03/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 847 shares @ $7.37, valued at $6.2k
Sold 26,546 shares @ $7.44, valued at $197.5k
Sold 200 shares @ $7.28, valued at $1.5k
02/28/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 2,500 shares @ $7.41, valued at $18.5k
Sold 8,152 shares @ $7.57, valued at $61.7k
Sold 3,100 shares @ $7.4, valued at $22.9k
02/23/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 4,898 shares @ $7.88, valued at $38.6k
Sold 4,100 shares @ $7.85, valued at $32.2k
Sold 29,299 shares @ $7.77, valued at $227.7k
02/17/2022 4 Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Sold 12,600 shares @ $8.33, valued at $105k
Sold 33,202 shares @ $7.99, valued at $265.3k
Sold 1,700 shares @ $7.98, valued at $13.6k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy